Locke Lord advised Imugene Ltd. on the transaction. Precision BioSciences, Inc. (Nasdaq: DTIL) announced it has completed a transaction with Imugene Limited (ASX: IMU) for global rights...
This content is for Standard 1 Year members only. LoginJoin Now